The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).
 
George Lau
Employment - Humanity & Health Medical Group
Leadership - Humanity & Health Medical Group
Consulting or Advisory Role - AstraZeneca
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Roche/Genentech; Sirtex Medical; TERUMO
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Roche; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Roche; Sirtex Medical
 
Oxana V. Crysler
Research Funding - ACCRU (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Wattana Sukeepaisarnjaroen
No Relationships to Disclose
 
Oleg Lipatov
No Relationships to Disclose
 
Manabu Morimoto
No Relationships to Disclose
 
Isabelle Archambeaud
No Relationships to Disclose
 
Valentina Burgio
No Relationships to Disclose
 
Le Thi Tuyet Phuong
No Relationships to Disclose
 
Yee Chao
No Relationships to Disclose
 
Jean-Marie Peron
No Relationships to Disclose
 
Marie-Luise Berres
Honoraria - AstraZeneca; Bristol-Myers Squibb/Sanofi; Lilly; MSD; Pierre Fabre; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Sanofi; Merck; Merck; Roche Pharma AG
 
Yoo-Joung Ko
No Relationships to Disclose
 
Carrie L. McCoy
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Charu Gupta
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mallory Makowsky
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Alejandra Negro
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - AstraZeneca; Autem Medical; Boehringer Ingelheim (I); Eisai; Exelixis; Helio Health; Incyte; Ipsen; Merck Serono; Newbridge Pharmaceuticals; Novartis (I); QED Therapeutics; Roche/Genentech; SERVIER; Yiviva
Research Funding - Arcus Ventures (Inst); AstraZeneca (Inst); BioNtech (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Helsinn Healthcare (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Yiviva (Inst)